The Journal of Heart and Lung Transplantation
Volume 23, Issue 11 , Pages 1245-1251 , November 2004

Effect of late medication non-compliance on outcome after heart transplantation: A 5-year follow-up

  • Fabienne Dobbels, MSc

      Affiliations

    • Center for Health Services and Nursing Research, School of Public Health, Faculty of Medicine, Leuven, Belgium
    • Leuven Heart Transplant Program, University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium
    • ,
  • Sabina De Geest, RN, PhD

      Affiliations

    • Center for Health Services and Nursing Research, School of Public Health, Faculty of Medicine, Leuven, Belgium
    • Institute of Nursing Science, University of Basel, Basel, Switzerland
    • Corresponding Author InformationReprint requests Sabina De Geest, PhD, Center for Health Services and Nursing Research, School of Public Health, Kapucijnenvoer 35/4, B-3000 Leuven, Belgium. Telephone: +32-16-33-69-75. Fax: +32-16-33-69-70.
    • ,
  • Johan van Cleemput, MD, PhD

      Affiliations

    • Leuven Heart Transplant Program, University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium
    • ,
  • Walter Droogne, MD

      Affiliations

    • Leuven Heart Transplant Program, University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium
    • ,
  • Johan Vanhaecke, MD, PhD

      Affiliations

    • Leuven Heart Transplant Program, University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium

Received 18 March 2003 ,Revised 31 July 2003 ,Accepted 10 September 2003.

References 

  1. World Health Organization . Adherence to Long-term Therapies. Evidence for Action. Switzerland: World Health Organization; 2003;
  2. De Geest S, Abraham I, Moons P, et al.  Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant. 1998;17:854–863
  3. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant. 1996;15:631–645
  4. Grady KL, Jalowiec A, White-Williams C. Patient compliance at one year and two years after heart transplantation. J Heart Lung Transplant. 1998;17:383–394
  5. Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999;18:549–562
  6. Nevins TE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int. 2001;60:1565–1570
  7. Urquhart J. The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharamcokinet. 1997;32:345–356
  8. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273–3277
  9. Dunbar-Jacob J, Sereika S, Rohay JM, et al.  Electronic methods of assessing adherence to medical regimens. In:  Krantz D,  Baum A editor. Technologies and Methods in Behavioral Medicine. Mahwah, NJ: Lawrence Erlbaum Associates; 1995;
  10. De Geest S, Vanhaecke J. Methodological issues in transplant compliance research. Transplant Proc. 1999;31(suppl 4A):81S–83S
  11. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074–1090
  12. Billingham ME, Cary NR, Hammond ME, et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection (Heart rejection study group). J Heart Transplant. 1990;9:587–593
  13. Cimato TR, Jessup M. Recipient selection in cardiac transplantation (Contraindications and risk factors for mortality). J Heart Lung Transplant. 2002;21:1161–1173
  14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  15. Willett WC, Manson JE, Stampfer MJ, et al.  Weight, weight change, and coronary heart disease in women. Risk within the ‘normal’ weight range. JAMA. 1995;273:461–465
  16. Reichart B, Meiser B, Vigano M, et al.  European Multicenter Tacrolimus (FK 506) Heart Pilot Study (One-year results—european tacrolimus multicenter heart study group). J Heart Lung Transplant. 1998;17:775–781
  17. Taylor DO, Barr ML, Radovancevic B, et al.  A randomised, mulitcenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation (decreased hyperlipidemia and hypertension with tacrolimus). J Heart Lung Transplant. 1999;18:336–345
  18. Kobashigawa J, Miller L, Renlund D, et al.  A randomised active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation. 1998;66:507–515
  19. Registry of the International Society for Heart and Lung Transplantation. 2003; available at http://www.ishlt.org, accessed
  20. Trulock EP, Edwards LB, Taylor DO, et al.  The Registry of the International Society for Heart and Lung Transplant report—2003. J Heart Lung Transplant. 2003;22:625–635
  21. Felkel TO, Smith AL, Reichenspurner HC, et al.  Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy. J Heart Lung Transplant. 2002;21:530–539
  22. Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani R. Interventions for helping patients to follow prescriptions for medications (Cochrane Review). In: Oxford: The Cochrane Library; 2000; Issue 4. Update Software
  23. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance (A meta-analysis). Med Care. 1998;36:1138–1161
  24. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA. 2002;288:2868–2879
  25. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60:657–665
  26. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes (A meta-analysis). Med Care. 2002;40:794–811
  27. World Health Organization . Innovative Care for Chronic Conditions (Building Blocks for Action (Global Report)). Switzerland: World Health Organization; 2002;

PII: S1053-2498(03)00472-8

doi: 10.1016/j.healun.2003.09.016

The Journal of Heart and Lung Transplantation
Volume 23, Issue 11 , Pages 1245-1251 , November 2004

Article Tools

* Image Usage & Resolution